Approvals for ‘Tamifly’ generics about to pour out for bioequivalence tests
Approvals for generics of ‘Tamiflu,’ a influenza virus treatment whose patent is expiring on the 22nd of August, are pouring out.
According to the Ministry of Food and Drug Safety(MFDS) on the 25th, 15 generic drugs of ‘Tamiflu(generic name: oseltamivir phosphate)’ expiring on the 22nd of August...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.